PROCEPT BioRobotics Files 2024 10-K

Ticker: PRCT · Form: 10-K · Filed: Feb 27, 2025 · CIK: 1588978

Sentiment: neutral

Topics: 10-K, annual-report, medical-devices

TL;DR

PROCEPT BioRobotics filed its 2024 10-K. Full financials and biz details inside.

AI Summary

PROCEPT BioRobotics Corp filed its 2024 10-K on February 27, 2025, reporting its financial performance for the fiscal year ending December 31, 2024. The filing details the company's operations in the surgical and medical instruments sector, headquartered in San Jose, California. Key financial data and operational highlights for 2024 are presented within this comprehensive annual report.

Why It Matters

This 10-K filing provides investors and stakeholders with a detailed overview of PROCEPT BioRobotics Corp's financial health, strategic initiatives, and risks for the fiscal year 2024, crucial for investment decisions.

Risk Assessment

Risk Level: medium — As a medical device company, PROCEPT BioRobotics faces risks related to regulatory approvals, market adoption, competition, and potential product liabilities.

Key Numbers

Key Players & Entities

FAQ

What is the primary business of PROCEPT BioRobotics Corp?

PROCEPT BioRobotics Corp operates in the Surgical & Medical Instruments & Apparatus industry, as indicated by its SIC code 3841.

When did PROCEPT BioRobotics Corp file its 2024 10-K?

The 10-K filing for the fiscal year ending December 31, 2024, was filed on February 27, 2025.

Where is PROCEPT BioRobotics Corp headquartered?

The company's business and mailing address is listed as 150 BAYTECH DRIVE, SAN JOSE, CA 95134.

What is the SEC file number for PROCEPT BioRobotics Corp?

The SEC file number for PROCEPT BioRobotics Corp is 001-40797.

What is the state of incorporation for PROCEPT BioRobotics Corp?

PROCEPT BioRobotics Corp is incorporated in Delaware (DE).

Filing Details

This Form 10-K (Form 10-K) was filed with the SEC on February 27, 2025 regarding PROCEPT BioRobotics Corp (PRCT).

View full filing on EDGAR

View Full Filing

View this 10-K filing on SEC EDGAR

View on Read The Filing